The impact of non-communicable diseases (NCDs) in populations extends beyond ill-health
and mortality with large financial consequences. To systematically review and meta-analyze …

Non-communicable diseases are now the number one cause of disabilities and loss of life
expectancy. Among them, chronic respiratory conditions constitute a major class. The …

BACKGROUND The morbidity and mortality associated with COPD exacts a considerable
economic burden. Comorbidities in COPD are associated with poor health outcomes and …

Summary Background Medication for Chronic Obstructive Pulmonary Disease (COPD) has
shown to substantially reduce symptoms and slow progression of disease. However, non …

Medication non-adherence to asthma and chronic obstructive pulmonary disease therapy
poses a significant burden for patients and societies. Non-adherence encompasses poor …

Non-communicable diseases (NCDs) have large economic impact at multiple levels. To
systematically review the literature investigating the economic impact of NCDs [including …

Different molecular subtypes of glioblastoma (GBM) have been recently identified, of which
the mesenchymal subtype is associated with worst prognoses. Here, we report that …

Abstract Background Non-communicable diseases (NCDs) impose a significant and
growing burden on the health care system and overall economy of developed (and …

Adherence to medication comprises a multiphased temporal process involving (1) initiation
of prescribed therapy,(2) implementation as prescribed, and (3) subsequent persistence …

Background The PHARMACOP-intervention significantly improved medication adherence
and inhalation technique for patients with COPD compared with usual care. This study …